Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 5Unknown 2Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Giant Cell Tumor of Bone 2Breast Neoplasms 2Thyroid Cancer Metastatic 1Osteoporotic Fractures 1Osteoporosis 1Osteopetrosis, mild autosomal recessive form 1Osteopetrosis, Autosomal Recessive 7 1Osteoblastoma 1Neoplasm Metastasis 1Musculoskeletal Pain 1Melanoma 1Kidney Neoplasms 1Granuloma, Giant Cell 1Chondroblastoma 1Carcinoma, Renal Cell 1Bone Metastasis From Solid Tumors 1Bone Metastases From Solid Tumors 1Bone Metastases 1Bone Cysts, Aneurysmal 1Arthralgia 1

Interventions

Denosumab 2Vitamin D 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Giant Cell Tumor of Bone × Denosumab × Clear all
NCT03358212 2017-11-30

Safety and Efficacy of Post-operative Denosumab Strategy for Giant Cell Tumor of Bone Treatment in China

Peking University People's Hospital

Unknown
100 enrolled

Giant Cell Tumor of Bone

NCT03259152 2017-08-24

D-Gct

Hebei Medical University Third Hospital

Phase 3 Unknown
30 enrolled

Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡